ArticleDiabetes, obesity & metabolism2026
Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsAlthough the American Diabetes Association (ADA) recently established a diagnostic algorithm for the early detection of liver fibrosis among high-risk individuals, its implications for chronic kidney disease (CKD) risk stratification remain unclear. We investigated whether the ADA diagnostic algorithm can effectively stratify CKD risk in individuals at risk of cirrhosis. MATERIALS AND
methodsThis retrospective cohort study included 9264 adults without pre-existing CKD who underwent vibration-controlled transient elastography from April 2006 to October 2018. Participants were categorized into three groups: (1) no metabolic criteria; (2) low-risk (FIB-4 < 1.3 or 1.3-2.67 with liver stiffness [LS] < 8 kPa) and (3) high risk (FIB-4 > 2.67, or 1.3-2.67 with LS ≥ 8 kPa). The primary outcome was incident CKD, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m
resultsDuring a mean follow-up of 3.7 years, 440 (4.7%) participants developed incident CKD. When stratified by the ADA algorithm, multivariable Cox models revealed a 1.52-fold (95% confidence interval [CI], 1.09-2.13) higher risk of incident CKD in the high-risk group than those with no metabolic abnormalities. The high-risk group also had a 2.30-fold higher risk (95% CI, 1.83-2.90) of a 25% eGFR decline (mean follow-up 3.5 years) than those with no metabolic abnormalities.
conclusionsThe two-step ADA algorithm can effectively stratify CKD risk in individuals at high risk of future cirrhosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.